SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 7)*
CONSORTIUM G DINA GROUP, INC. (CONSORCIO G GRUPO DINA S.A. DE C.V.)
-------------------------------------------------------------------
(Name of Issuer)
SERIES L AMERICAN DEPOSITARY SHARES
------------------------------------------
(Title of Class of Securities)
210306-20-5
(Cusip Number)
RICHARD C. PFENNIGER, JR., 4400 BISCAYNE BOULEVARD, MIAMI, FL 33137
(305) 575-6000
-------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
OCTOBER 8, 1997
-------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of the Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with the statement [ ] (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
NOTE: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filed out for a reporting person's
initial on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter disclosures
provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 9
<PAGE>
- --------------------------------------------------------------------------------
CUSIP NO. 210306-20-5 13D PAGE 2 OF 9 PAGES
-----------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
PHILLIP FROST, M.D.
SS# ###-##-####
- --------------------------------------------------------------------------------
2 Check the appropriate Box if a Member of a Group (a) [X]
(b) [_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
N/A
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [_]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 0
BENEFI- ----------------------------------------------------
CIALLY 8 SHARED VOTING POWER
OWNED BY 1,738,803
EACH ----------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 0
WITH ----------------------------------------------------
10 SHARED DISPOSITIVE POWER
1,738,803
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,738,803
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [_]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.4%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
<PAGE>
- --------------------------------------------------------------------------------
CUSIP NO. 210306-20-5 13D PAGE 3 OF 9 PAGES
- --------------------------------------------------------------------------------
1 NAME OF REPORTING
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
FROST-NEVADA, LIMITED PARTNERSHIP
IRS I.D. #59-2749083
- --------------------------------------------------------------------------------
2 Check the appropriate Box if a Member of a Group (a) [X]
(b) [_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
N/A
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [_]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
NEVADA
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 0
BENEFI- ----------------------------------------------------
CIALLY 8 SHARED VOTING POWER
OWNED BY 1,738,803
EACH ----------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 0
WITH ----------------------------------------------------
10 SHARED DISPOSITIVE POWER
1,738,803
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,738,803
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [_]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.4%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
PN
- --------------------------------------------------------------------------------
<PAGE>
- --------------------------------------------------------------------------------
CUSIP NO. 210306-20-5 13D PAGE 4 OF 9 PAGES
-----------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
FROST-NEVADA CORPORATION
IRS I.D. #59-2749057
- --------------------------------------------------------------------------------
2 Check the appropriate Box if a Member of a Group (a) [X]
(b) [_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
N/A
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [_]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
NEVADA
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 0
BENEFI- ----------------------------------------------------
CIALLY 8 SHARED VOTING POWER
OWNED BY 1,738,803
EACH ----------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 0
WITH ----------------------------------------------------
10 SHARED DISPOSITIVE POWER
1,738,803
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,738,803
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [_]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.4%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
<PAGE>
Item 1. SECURITY AND ISSUER.
This is Amendment No. 7 to the Schedule 13D previously filed
by Phillip Frost, M.D., Frost-Nevada, Limited Partnership (the "Partnership"),
and Frost-Nevada Corporation (collectively, the "Reporting Persons"), with
respect to Series L American Depositary Shares (the "Shares") of Consorcio G
Grupo Dina, S.A. de C.V. (the "Issuer"). Each Share represents four shares of
Series L Stock of the Issuer. The principal executive offices of the Issuer are
located at Tlacoquemecatl 41, Col. del Valle 03100, Mexico City, Mexico.
Information regarding each of the Reporting Persons is set forth below.
Item 2. IDENTITY AND BACKGROUND.
Item 2 is amended and restated in its entirety as follows:
Dr. Frost's present principal occupation is as Chairman of the
Board of Directors and Chief Executive Officer of IVAX Corporation, a Florida
corporation, which through its subsidiaries is engaged primarily in the
research, development, manufacturing, marketing and distribution of health care
products. Dr. Frost's principal business address is 4400 Biscayne Boulevard,
Miami, Florida 33137.
The Partnership is a limited partnership organized and
existing under the laws of the State of Nevada with its principal office and
business address located at 3500 Lakeside Court, Suite 200, Reno, Nevada 89509.
The principal business of the Partnership is the investment in marketable
securities, precious metals and commodities and real estate located in Nevada.
Frost- Nevada Corporation is the sole general partner, and Dr. Frost is the sole
limited partner, of the Partnership.
Frost-Nevada Corporation is a corporation organized and
existing under the laws of the State of Nevada with its principal office and
business address located at 3500 Lakeside Court, Suite 200, Reno, Nevada 89509.
The principal business of Frost-Nevada Corporation is acting as the general
partner of the Partnership. Dr. Frost is the sole shareholder and an officer and
a director of Frost-Nevada Corporation. Neil Flanzraich is a director and an
officer of Frost- Nevada Corporation. Neil Flanzraich's present principal
occupation is as an attorney with the law firm of Heller, Ehrman, White &
McAuliffe. Mr. Flanzraich's principal business address is 525 University Avenue,
Palo Alto, California 94301-1900.
To the best knowledge of each of the Reporting Persons,
neither such Reporting Person nor Mr. Flanzraich has been convicted in any
criminal proceeding (excluding traffic violations and similar misdemeanors), or
was a party to any civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding was subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
activity subject to, federal or state securities laws or finding any violation
with respect to such laws during the last five years. Each of Dr. Frost and Mr.
Flanzraich is a citizen of the United States.
Page 5 of 9
<PAGE>
Item 5. INTEREST IN SECURITIES OF THE ISSUER.
Item 5 is amended in its entirety and restated as follows:
AMOUNT OF SHARES PERCENTAGE
NAME BENEFICIALLY OWNED OF CLASS*
---- ------------------ ----------
Phillip Frost, M.D. 1,738,803** 12.4%
Frost-Nevada Corporation 1,738,803** 12.4%
Frost-Nevada, Limited 1,738,803** 12.4%
Partnership
- ----------------------------
* Based on 14,016,884 Shares outstanding on October 8, 1997, as reported
verbally by Morgan Guaranty Trust Company of New York, the depositary
of the Shares.
** These Shares are owned of record by one or more of the Reporting
Persons. As the sole limited partner of the Partnership and the sole
shareholder and an officer and a director of Frost-Nevada Corporation,
the general partner of the Partnership, Dr. Frost may be deemed a
beneficial owner of the Shares. Record ownership of the Shares may be
transferred from time to time among any or all of the Reporting
Persons. Accordingly, solely for purposes of reporting beneficial
ownership of the Shares pursuant to section 13(d) under the Securities
Exchange Act of 1934, as amended, each Reporting Person will be deemed
to be the beneficial owner of Shares held by any other Reporting
Person.
The Partnership shares the power to vote or dispose of the Shares
beneficially owned by it with Frost-Nevada Corporation and Dr. Frost.
Frost-Nevada Corporation, in its capacity as the general partner of the
Partnership, has the power to vote or direct the vote of these Shares or to
dispose or direct the disposition of these Shares for the Partnership.
Frost-Nevada Corporation will be deemed the beneficial owner of the Shares owned
by the Partnership by virtue of this relationship to the Partnership. Dr. Frost,
in his capacity as the sole shareholder and an officer and a director of
Frost-Nevada Corporation, the general partner of the Partnership, will be deemed
the beneficial owner of all Shares owned by the Partnership by virtue of his
power to vote or direct the vote of the Shares or to dispose or direct the
disposition of the Shares owned by the Partnership.
Other than as reported on Exhibit 2 attached hereto, none of
the Reporting Persons has engaged in any transaction involving Shares of the
Issuer during the past sixty days.
Item 7. MATERIAL TO BE FILED AS EXHIBITS.
1. Joint Filing Agreement
2. Description of transactions in the Issuer's Shares by Phillip
Frost, M.D.
3. Power of Attorney granted to Phillip Frost, M.D. by Neil
Flanzraich (incorporated by reference to Amendment No. 6 to
the Reporting Persons Statement on Schedule 13D with respect
to Consortium G. Dina Group, Inc. (Corsorcio G. Grupo Dina
S.A. de C.V.).
Page 6 of 9
<PAGE>
SIGNATURES
After reasonable inquiry and to the best of the undersigned's knowledge
and belief, the undersigned certify that the information set forth in this
Statement is true, complete and correct.
/S/ PHILLIP FROST, M.D.
------------------------------------------
Date: October 20, 1997 Phillip Frost, M.D.
FROST-NEVADA, LIMITED
PARTNERSHIP
*
------------------------------------------
Date: October 20, 1997 Neil Flanzraich
President of Frost-Nevada Corporation,
General Partner
FROST-NEVADA CORPORATION
*
------------------------------------------
Date: October 20, 1997 Neil Flanzraich
President
*By/S/ PHILLIP FROST, M.D.
-----------------------------------
Phillip Frost, M.D.
(Attorney-in-fact pursuant
to Power of Attorney)
Page 7 of 9
<PAGE>
EXHIBIT INDEX
EXHIBIT PAGE
- ------- ----
1 Joint Filing Agreement
2 Description of transactions in the Issuer's Shares
by Phillip Frost, M.D.
EXHIBIT 1
The undersigned hereby agree that this Amendment to the Schedule 13D
filed by us with respect to the Series L American Depositary Shares of Consorcio
G Grupo Dina, S.A. de C.V. is filed on behalf of each of us.
/S/ PHILLIP FROST, M.D.
---------------------------------------
Date: October 20, 1997 Phillip Frost, M.D.
FROST-NEVADA, LIMITED
PARTNERSHIP
*
---------------------------------------
Date: October 20, 1997 Neil Flanzraich
President of Frost-Nevada Corporation,
General Partner
FROST-NEVADA CORPORATION
*
---------------------------------------
Date: October 20, 1997 Neil Flanzraich
President
*By/S/ PHILLIP FROST, M.D.
-------------------------------------
Phillip Frost, M.D.
(Attorney-in-fact pursuant
to Power of Attorney)
EXHIBIT 2
Set forth below is a summary of transactions in the Series L American
Depositary Shares of the Issuer (each such Share representing four shares of
Series L Stock of the Issuer) by Phillip Frost, M.D. effected August 29, 1996
through the date of this Amendment No. 7. All transactions were open market
sales effected on the New York Stock Exchange.
NUMBER OF SHARES PRICE PER
DATE SOLD SHARE
- ---- ---------------- ---------
8/21/97 3,000 3.6875
9/22/97 100,000 2.70
10/3/97 5,000 4.625
10/6/97 10,000 4.625
10/7/97 10,500 4.625
10/8/97 15,000 4.625
10/8/97 5,000 4.6875
10/9/97 10,000 4.625
10/9/97 11,500 4.75
10/10/97 12,000 5.00
10/10/97 13,000 4.9375
